Effective March 15: CMS Rule Regarding Medicare Coverage of Innovative Technology (MCIT) and Definition of ‘Reasonable and Necessary’ Published: February 8, 2021 View
U.S. FDA Releases Artificial Intelligence and Machine Learning Action Plan Published: January 18, 2021 View
U.S. FDA Introduces Safer Technologies Program to Promote Safe, Early Access to Innovative Medical Devices Published: January 12, 2021 View
Preparing for a Pre-Submission Meeting En Route to Regulatory Approval Published: November 3, 2020 View
FDA Releases New Draft Guidance for Biocompatibility of Devices in Contact with Intact Skin Published: October 19, 2020 View
Key Considerations for Executing Clinical Trials for Dual 510(k) and CLIA Waiver Applications Published: August 11, 2020 View
FDA Releases Final Guidance on Bone Anchor Premarket Notification 510(k) Submissions Published: March 5, 2020 View
The Evolution of the Accreditation Scheme for Conformity Assessment (ASCA) for Medical Device Premarket Approval Published: December 3, 2019 View
Obtaining Actionable FDA Feedback: How to Develop Targeted Questions for Pre-Submission Meetings Published: January 23, 2018 View
The Importance of Human Factors & Usability Engineering in Medical Devices Published: October 9, 2017 View
Utilizing Biological Risk Assessments and Chemical Characterization to Reduce Medical Device Development Timelines Published: September 27, 2017 View